Aptimmune Biologics announces the addition of Jessica Seate, DVM, as a veterinarian for the company’s swine division. In her new role, Seate will help launch Aptimmune’s new porcine reproductive and respiratory syndrome virus and influenza vaccines made with Barricade formulation technology, as well as assist in the development of the company’s portfolio of swine vaccines.
“Dr. Seate’s extensive technical experience in swine vaccine marketing and practical experience in swine health and production makes her an ideal fit for our company,” says Aaron Gilbertie, CEO of Aptimmune Biologics. “She will be a tremendous asset to both our company and to our customers in helping them improve the health of their herds.”
Prior to joining Aptimmune, Seate worked for Boehringer Ingelheim Animal Health Inc., as a swine technical manager in their marketing department in St. Joseph, Mo. She also worked as a veterinarian for Smithfield Foods, where she was responsible for 50,000 sows and all the downstream production. Seate obtained her veterinary degree from Michigan State University.
Aptimmune Biologics, based in Champaign, Ill., specializes in developing and marketing a portfolio of revolutionary mucosal vaccines that provide answers for the most costly viral diseases impacting the swine industry. Aptimmune’s first vaccines are focused on addressing two major viral respiratory pathogens, PRRSV and influenza. To learn more, visit Aptimmune.com.
